Innovation Endeavors

The founding partnership of Eric Schmidt, Dror Berman, Scott Brady, and Rick Scanlon forms the core leadership. They operate alongside General Partners Harpi Singh and Davis Treybig, and Partners Kenneth Auchenberg and Nick Olsen. The firm emphasizes a collaborative, thesis-driven process rather than a single centralized decision-maker.

The firm relies on a prepared-mind research model and networks across technology, academia, and venture capital. It also runs Curiosity Camp, a convening platform for scientists, entrepreneurs, and industry leaders. The stated goal is to identify technical founders solving hard engineering and science problems before they broadly seek funding.

Innovation Endeavors operates as a traditional early-stage venture capital firm raising funds from external limited partners, not as a single family office. While founding partner Eric Schmidt's wealth and network are central to its origin, the firm manages pooled institutional capital.

The firm states it often leads or co-leads the rounds it invests in and takes board seats as a deeply committed investor. Initial investments typically range from $1 million to $15 million at the seed and Series A stages.

Biotechnology is a core pillar under the 'Engineering Health' vertical. The firm applies its 'Super Evolution' convergence thesis to medicine and diagnostics. Eikon Therapeutics, a biopharma company using live-cell microscopy for drug discovery that went public, is a named portfolio example.